![](/img/cover-not-exists.png)
Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing--remitting multiple sclerosis: 2-year results from the COGIMUS study
Patti, F., Pia Amato, M., Bastianello, S., Caniatti, L., Di Monte, E., Lijoi, F., Goretti, B., Messina, S., Picconi, O., Tola, M. R., Trojano, M.Volume:
2
Language:
english
Journal:
Therapeutic Advances in Neurological Disorders
DOI:
10.1177/1756285608101379
Date:
March, 2009
File:
PDF, 133 KB
english, 2009